WallStreetZenWallStreetZen

NYSE: SOLV
Solventum Corp Stock

Overview
ForecastEarningsRevenueDividendOwnership
$66.26+0.59 (+0.9%)
Updated Apr 17, 2025
SOLV Price
$66.26
Fair Value Price
N/A
Market Cap
$11.46B
52 Week Low
$47.16
52 Week High
$85.92
P/E
23.92x
P/B
3.87x
P/S
1.39x
PEG
0.75x
Dividend Yield
N/A
Revenue
$8.25B
Earnings
$479.00M
Gross Margin
55.6%
Operating Margin
11.79%
Profit Margin
5.8%
Debt to Equity
3.89
Operating Cash Flow
$1B
Beta
0.79
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine SOLV's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
View All “A” Zen Rated Stocks
→

Zen Rating Component Grades

B
Value
C
Growth
C
Momentum
C
Sentiment
B
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Health Information Service

Industry Rating
B
SOLV
Ranked#22 of 44

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
Nutex Health (NUTX)
$149.00A
Ge Healthcare Technologies (GEHC)
$62.37A
Carecloud (CCLD)
$1.42B
View Top Health Information Service Stocks

Be the first to know about important SOLV news, forecast changes, insider trades & much more!

SOLV News

Overview

Due Diligence Score

–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how SOLV scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SOLV ($66.26) is trading above its intrinsic value of $45.84, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
SOLV is good value based on its earnings relative to its share price (23.92x), compared to the US market average (27.98x)
P/E vs Market Valuation
SOLV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more SOLV due diligence checks available for Premium users.

Valuation

SOLV price to earnings (PE)

For valuing profitable companies with steady earnings

Company
23.92x
Industry
11.14x
Market
27.98x
SOLV is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SOLV is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

SOLV price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
3.87x
Industry
3.39x
SOLV is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SOLV price to earnings growth (PEG)

For valuing profitable companies with growth potential

SOLV is good value based... subscribe to Premium to read more.
PEG Value Valuation

SOLV's financial health

Profit margin

Revenue
$2.1B
Net Income
$31.0M
Profit Margin
1.5%
SOLV's Earnings (EBIT) of $973.00M... subscribe to Premium to read more.
Interest Coverage Financials
SOLV's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$14.5B
Liabilities
$11.5B
Debt to equity
3.89
SOLV's short-term assets ($3.25B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SOLV's long-term liabilities ($8.80B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SOLV's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$219.0M
Investing
-$127.0M
Financing
-$104.0M
SOLV's operating cash flow ($1.19B)... subscribe to Premium to read more.
Debt Coverage Financials

SOLV vs Health Information Service Stocks

TickerZen RatingMarket Cap1d %P/EP/B
SOLVC$11.46B+0.90%23.92x3.87x
DOCSB$9.98B+0.81%49.27x9.68x
HQYC$7.31B+2.46%76.14x3.46x
WAYB$6.27B-0.71%-280.38x2.04x
BTSGC$2.90B-1.25%-184.44x1.76x
View Top Health Information Service Stocks

Solventum Stock FAQ

What is Solventum's quote symbol?

(NYSE: SOLV) Solventum trades on the NYSE under the ticker symbol SOLV. Solventum stock quotes can also be displayed as NYSE: SOLV.

If you're new to stock investing, here's how to buy Solventum stock.

What is the 52 week high and low for Solventum (NYSE: SOLV)?

(NYSE: SOLV) Solventum's 52-week high was $85.92, and its 52-week low was $47.16. It is currently -22.88% from its 52-week high and 40.5% from its 52-week low.

How much is Solventum stock worth today?

(NYSE: SOLV) Solventum currently has 172,990,490 outstanding shares. With Solventum stock trading at $66.26 per share, the total value of Solventum stock (market capitalization) is $11.46B.

Solventum stock was originally listed at a price of $69.10 in Apr 1, 2024. If you had invested in Solventum stock at $69.10, your return over the last 1 years would have been -4.11%, for an annualized return of -4.11% (not including any dividends or dividend reinvestments).

How much is Solventum's stock price per share?

(NYSE: SOLV) Solventum stock price per share is $66.26 today (as of Apr 17, 2025).

What is Solventum's Market Cap?

(NYSE: SOLV) Solventum's market cap is $11.46B, as of Apr 21, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Solventum's market cap is calculated by multiplying SOLV's current stock price of $66.26 by SOLV's total outstanding shares of 172,990,490.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.